Results per Page:
Patient stories, provider advice mark invasive lobular breast cancer awareness event
Fred Hutch experts discuss ILC’s hormonal risk factors, screening recommendations and new research
Women’s Health Initiative: Research that keeps on giving
Three decades in, longstanding ‘team science’ study continues to provide answers to health issues facing older women
Women’s Health Initiative continues on at Fred Hutch
Nearly 30 years after its launch, the WHI and its data are still going strong, producing key findings
Understanding Angelina Jolie Pitt’s medical choices
Actress, filmmaker lauded for raising awareness and saving lives, but her actions also bring up questions
The value of the combined hormone therapy trial, weighed in lives saved, billions of dollars
The landmark study that prompted millions of women to stop taking combined hormone therapy resulted in $37.1 billion net economic return, thousands of lives saved, a new study finds
Combined hormone therapy increases risk of lobular breast cancer fourfold after just three years of use
Fred Hutchinson Cancer Research Center leads first study designed to evaluate the association between combined HRT use and the risk of lobular breast cancers